Sunshine Biopharma Inc. Gain (Loss) on Disposition of Assets for Financial Service Operations
Sunshine Biopharma Inc. (SBFM) reported Gain (Loss) on Disposition of Assets for Financial Service Operations of -$10.26 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnSalesOfAssets · last filed 2026-04-03
- Sunshine Biopharma Inc. gain (loss) on disposition of assets for financial service operations for the quarter ending 2025-12-31 was -$7.00.
- Sunshine Biopharma Inc. gain (loss) on disposition of assets for financial service operations for the quarter ending 2025-09-30 was -$10.25K.
- Sunshine Biopharma Inc. gain (loss) on disposition of assets for financial service operations for the quarter ending 2024-12-31 was $0.00.
- Sunshine Biopharma Inc. gain (loss) on disposition of assets for financial service operations for the quarter ending 2024-09-30 was $0.00.
- Sunshine Biopharma Inc. gain (loss) on disposition of assets for financial service operations for fiscal 2025 was -$10.26K.
- Sunshine Biopharma Inc. gain (loss) on disposition of assets for financial service operations for fiscal 2024 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets for Financial Service Operations 3 month | Gain (Loss) on Disposition of Assets for Financial Service Operations 6 month | Gain (Loss) on Disposition of Assets for Financial Service Operations 9 month | Gain (Loss) on Disposition of Assets for Financial Service Operations 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$7.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03 | -$10.26K derived: sum of 2 quarters · filed 2026-04-03 | -$10.26K 10-K · filed 2026-04-03 | |
| 2025-09-30 | -$10.25K 10-Q · filed 2025-11-13 | -$10.25K 10-Q · filed 2025-11-13 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03 | $0.00 derived: sum of 2 quarters · filed 2026-04-03 | $0.00 10-K · filed 2026-04-03 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |